Income Statement (SURROZEN)

SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Surrozen or the Company) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modula… [+18545 chars]...

Surrozen, Inc. (NASDAQ:SRZN – Free Report) – Equities researchers at HC Wainwright cut their Q2 2025 earnings estimates for Surrozen in a report released on Monday, May 12th. HC Wainwright analyst M.… [+3770 chars]...

Surrozen (NASDAQ:SRZN – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $32.00 target p… [+3255 chars]...

Omega Therapeutics (NASDAQ:OMGA – Get Free Report) and Surrozen (NASDAQ:SRZN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two business… [+5147 chars]...

Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -in… [+9220 chars]...